Clinical Study of Allergic Rhinitis Therapy by Stem Cells
NCT05151133
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Allergic Rhinitis
Interventions
BIOLOGICAL:
Low dose UCMSCs
BIOLOGICAL:
Moderate dose UCMSCs
BIOLOGICAL:
High dose UCMSCs
Sponsor
Yantai Yuhuangding Hospital